Immune Pharmaceuticals
New York, US
Find your way into Immune Pharmaceuticals
Sign up to see every warm intro you have to Immune Pharmaceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Immune Pharmaceuticals team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
DG
Daniel G. TeperChairman and Chief Executive Officer
Board
RL
Rene LererBoard director
AS
Ana StancicBoard director
DK
Daniel KazadoBoard director
DS
David SidranskyBoard director
IK
Isaac KobrinBoard director
Reported raises · per SEC filings
Form D private placements$11.7M disclosed across 1 round · 2014
▶$11.7MraisedApr 2014 · 42 investors · PharmaceuticalsRule 506(b)
▶$11.7MraisedApr 2014 · 42 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Rene LererDirector
- Ana StancicDirector
- Daniel KazadoDirector
- Daniel G. TeperExecutive Officer, Director
- David SidranskyDirector
- Isaac KobrinDirector
- Offering amount
- $11.7M
- Amount sold
- $11.7M
- Sales commissions
- $544.6K
- Placement agents
- Chardan Capital Markets LLC
- First sale
- Mar 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Immune Pharmaceuticals?
- Immune Pharmaceuticals was founded by Daniel G. Teper.
- How much funding has Immune Pharmaceuticals raised?
- Immune Pharmaceuticals has disclosed $11.7M raised across 1 round.
- Where is Immune Pharmaceuticals headquartered?
- Immune Pharmaceuticals is headquartered in New York, US.